June 18, 2019 / 12:18 PM / 2 months ago

BRIEF-Health Canada Approves Hemlibra For Hemophilia A Patients Without Factor VIII Inhibitors

June 18 (Reuters) - Roche Holding AG:

* HEALTH CANADA APPROVES HEMLIBRA® FOR HEMOPHILIA A PATIENTS WITHOUT FACTOR VIII INHIBITORS

* HOFFMANN-LA ROCHE LIMITED SAYS HEALTH CANADA HAS APPROVED HEMLIBRA FOR HEMOPHILIA A Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below